Skip to main content
SpringerLink
Log in

The Effects of Antihypertensive Drugs on Serum Lipids and Lipoproteins

I. Diuretics

  • Review Article
  • Published:
Drugs Aims and scope Submit manuscript

Summary

Potassium-losing diuretic drugs, when used in the treatment of hypertension, cause unfavourable short term alterations in blood lipid and lipoprotein concentrations. The disturbance is characterised by increases in total cholesterol of 4 to 13%, in low density lipoprotein (LDL) cholesterol of 7 to 29%, in very-low density lipoprotein (VLDL) cholesterol of 7 to 56%, and in total triglyceride of 14 to 37%. The disturbance is variable among patients and over time in individual patients; it is absent in some. In long term treatment the data are fragmentary, but total cholesterol and triglycerides usually return to baseline values or below.

The variability of the lipid response to diuretics has several consequences: firstly, it necessitates a sizeable study population (minimum of 30 patients) in order to document convincingly its presence or absence; secondly, lipoprotein fractions must be examined to define the pattern of the disturbance; and thirdly, the subsidence of the diuretic-induced lipid effects in long term treatment may be more apparent than real because even larger decreases have been noted in untreated groups in the few studies that wisely included these important controls for comparison. While the cause of the lipid-lipoprotein aberration is unclear, existing data suggest that certain attributes of the study population influence the response, i.e. age, habitual diet, hormonal milieu (gender), baseline cholesterol concentrations, and induced glucose intolerance. The apparent absence of lipid alterations with indapamide needs to be substantiated and compared with low doses of a standard thiazidetype drug.

The lipid-lipoprotein effects of diuretics seem inconsequentially small, but they may contribute to the disappointing failure of diuretic-based regimens to lower the incidence of coronary heart disease in hypertensive patients. Nevertheless, diuretic-based treatment remains the only therapeutic regimen of proven benefit to congestive heart failure in patients with hypertension, and it is superior to β-blockade in preventing stroke. Hence, alternative antihypertensive drug regimens must be compared prospectively with diuretics in order to verify any theoretic superiority.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  • Amery A, Birkenhager N, Brixko P, Bulpitt C, Clement D, et al. Mortality and morbidity results from the European Working Party on High Blood Pressure in the Elderly Trial. Lancet 1: 1349–1354, 1985

    Article  PubMed  CAS  Google Scholar 

  • Amery A, Birkenhager W, Bulpitt C, Clement D, Deruyttere M, et al. Influence of antihypertensive therapy on serum cholesterol in elderly hypertensive patients. Acta Cardiologica 37: 235–244, 1982

    PubMed  CAS  Google Scholar 

  • Ames RP, Hill P. Elevation of serum lipid levels during diuretic therapy of hypertension. American Journal of Medicine 61: 748–757, 1976

    Article  PubMed  CAS  Google Scholar 

  • Ames RP, Hill P. Raised serum lipid concentrations during diuretic treatment of hypertension: a study of predictive indexes. Clinical Science and Molecular Medicine 55 (Suppl.4): 311S–314S, 1978

    CAS  Google Scholar 

  • Ames RP, Hill P. Improvement of glucose tolerance and lowering of glycohemoglobin and serum lipid concentrations after discontinuation of antihypertensive drug therapy. Circulation 65: 899–904, 1982a

    Article  PubMed  CAS  Google Scholar 

  • Ames RP, Hill P. Antihypertensive therapy and the risk of coronary heart disease. Journal of Cardiovascular Pharmacology 4 (Suppl. 2): S206–S212, 1982b

    PubMed  Google Scholar 

  • Ames RP, Hill P. Disturbance in serum total cholesterol and lipoprotein cholesterol ratios during control of hypertension with beta-adrenoceptor blocking drugs. Abstract. Clinical Research 30: 630A, 1982

    Google Scholar 

  • Ames RP, Peacock P. Serum cholesterol during treatment of hypertension with diuretic drugs. Archives of Internal Medicine 144: 710–714, 1984

    Article  PubMed  CAS  Google Scholar 

  • Basabe J, Grant A, Johnson B, Krees S, Lopez N, et al. Structural modification of therapeutic agents and their effect on insulin secretion. Proceedings of the Seventh Congress of the International Diabetes Federation, pp. 476–484, Excerpta Medica, Amsterdam, 1971

    Google Scholar 

  • Bauer JH, Brooks CS, Weinstein J, Wilcox HH, Heimberg M, et al. Effects of diuretic and propranolol on plasma lipoprotein lipids. Clinical Pharmacology and Therapeutics 30: 35–43, 1981

    Article  PubMed  CAS  Google Scholar 

  • Beling S, Vukovich RA, Neiss ES, Zisblatt MS, Webb E, et al. Long-term experience with indapamide. American Heart Journal 106: 258–262, 1983

    Article  PubMed  CAS  Google Scholar 

  • Berglund G, Andersson O. Beta-blockers or diuretics in hypertension? A six-year follow-up of blood pressure and metabolic side effects. Lancet 1: 744–747, 1981

    Article  PubMed  CAS  Google Scholar 

  • Berglund G, Sannerstedt R, Andersson O, Wedel H, Wilhelmsen L, et al. Coronary heart disease after treatment of hypertension. Lancet 1: 1–5, 1978

    Article  PubMed  CAS  Google Scholar 

  • Boehringer K, Meier A, Weidmann P, Schiffl H, Mordasini R, et al. Einfluss von Hydrochlorothiazid/Amiloride allein oder in Kombination mit a-Methyldopa auf die Serumlipoproteine. Schweizerische Medizinische Wochenschrift 111: 525–530, 1981

    PubMed  CAS  Google Scholar 

  • Boehringer K, Weidmann P, Mordasini R, Schiffl H, Bachmann C, et al. Menopause-dependent plasma lipoprotein alterations in diuretic-treated women. Annals of Internal Medicine 97: 206–209, 1982

    PubMed  CAS  Google Scholar 

  • Bottiger LE, Carlson LA. Risk factors for ischemic vascular death for men in the Stockholm prospective study. Atherosclerosis 36: 389–408, 1980

    Article  Google Scholar 

  • Breckenridge A, Dollery CT, Welborn TA, Fraser R. Glucose tolerance in hypertensive patients on long-term diuretic therapy. Lancet 1: 61–64, 1967

    Article  PubMed  CAS  Google Scholar 

  • Chrysant SG, Neller GK, Dillard B, Frohlich ED. Effects of diuretics on lipid metabolism in patients with essential hypertension. Angiology 27: 707–711, 1976

    Article  PubMed  CAS  Google Scholar 

  • Colodi G, Cevaro G, Lombardo F, Moratti P, Cicuttini L, et al. L’indapamide nei trattamento dell’ ipertensione arteriosa essenziale dell’ anziano: influenza sui metabolismo glico-lipidico. Bollettino della Societa Italiana di Cardiologia 26: 1527–1530, 1981

    PubMed  CAS  Google Scholar 

  • Colton T. Statistics in medicine, Little, Brown and Company, Boston, 1974

    Google Scholar 

  • Crane MG, Harris JJ. Effect of spironolactone in hypertensive patients. American Journal of the Medical Sciences 260: 311–330, 1970

    Article  PubMed  CAS  Google Scholar 

  • Crisp AJ, Kennedy PGE, Hoffbrand BI, Ebutt AF, Carruthers M. Lipids and lipoprotein fractions after cyclopenthiazide and oxprenolol: a double-blind crossover study. Current Medical Research and Opinion 7: 101–103, 1980

    Article  PubMed  CAS  Google Scholar 

  • DeCarvalho JGR, Dunn FG, Chrysant SG, Frohlich ED. Ticrynafen, a novel uricosuric antihypertensive natriuretic agent. Archives of Internal Medicine 138: 53–57, 1978

    Article  CAS  Google Scholar 

  • Fajans SS, Floyd Jr JC, Knopf RF, Rull J, Guntsche EM, et al. Benzothiadiazine suppression of insulin release from normal and abnormal islet tissue in man. Journal of Clinical Investigation 45: 481–492, 1966

    Article  PubMed  CAS  Google Scholar 

  • Freis ED. Should mild hypertension be treated? New England Journal of Medicine 307: 306–309, 1981

    Article  Google Scholar 

  • Ginsberg H, Olefsky J, Kimmerling G, Crapo P, Reaven G. Induction of hypertriglyceridemia by a low fat diet. Journal of Clinical Endocrinology and Metabolism 42: 729–735, 1976

    Article  PubMed  CAS  Google Scholar 

  • Glück Z, Baumgartner G, Weidmann P, Peheim E, Bachmann C, et al. Increased ratio between serum beta- and alpha-lipoproteins during diuretic therapy: an adverse effect? Clinical Science and Molecular Medicine 55: 325S–328S, 1978

    Google Scholar 

  • Glück Z, Weidmann P, Mordasini R, Peheim E, Bachmann C, et al. Einfluss einer diureticktherapie auf die serumlipoproteine: ein unerwünschter effect? Schweizerische Medizinische Wochenschrift 109: 104–108, 1979

    PubMed  Google Scholar 

  • Glück Z, Weidmann P, Mordasini R, Bachmann C, Riesen W, et al. Increased serum low-density lipoprotein cholesterol in men treated short-term with the diuretic chlorthalidone. Metabolism 29: 240–245, 1980

    Article  PubMed  Google Scholar 

  • Goldman AI, Steele BW, Schnaper HW, Fitz AE, Frohlich ED, et al. Serum lipoprotein levels during chlorthalidone therapy. Journal of the American Medical Association 224: 1691–1695, 1980

    Article  Google Scholar 

  • Gordon T, Kannel WB. Premature mortality from coronary heart disease: the Framingham study. Journal of the American Medical Association 215: 1617–1625, 1971

    Article  PubMed  CAS  Google Scholar 

  • Greenberg G, Brennan PJ, Miall WE. Effects of diuretic and beta-blocker therapy in the Medical Research Council Trial. American Journal of Medicine 76(2A): 45–51, 1984

    Article  PubMed  CAS  Google Scholar 

  • Grimm Jr RH, Leon AS, Hunninghake DB, Lenz K, Hannan P, et al. Effects of thiazide diuretics on plasma lipids and lipoproteins in mildly hypertensive patients. Annals of Internal Medicine 94: 7–11, 1981

    PubMed  Google Scholar 

  • GrimmJr RH, Leon AS, Hunninghake DB, Blackburn H. Diuretics and plasma lipids: effects of thiazides and spironolactone; in Noseda et al. (Eds) Lipoproteins and coronary atherosclerosis, pp. 371–376, Elsevier Biomedical Press, Amsterdam, 1982

    Google Scholar 

  • Grimm Jr RH, Neaton JD, McDonald M, Case J, McGill E, et al. Beneficial effects from systematic dosage reduction of the diuretic, chlorthalidone: a randomized study within a clinical trial. American Heart Journal 109: 858–865, 1985

    Article  PubMed  Google Scholar 

  • Helderman JH, Elahi D, Andersen KD, Raises GS, Tobin JD, et al. Prevention of the glucose intolerance of thiazide diuretics by maintenance of body potassium. Diabetes 32: 106–111, 1983

    Article  PubMed  CAS  Google Scholar 

  • Helgeland A. Treatment of mild hypertension: a five-year controlled drug trial. The Oslo study. American Journal of Medicine 69: 725–732, 1980

    Article  CAS  Google Scholar 

  • Helgeland A, Hjermann I, Holme I, Leren P. Serum triglycerides and serum uric acid in untreated and thiazide-treated patients with mild hypertension. American Journal of Medicine 64: 34–38, 1978a

    Article  PubMed  CAS  Google Scholar 

  • Helgeland A, Hjermann I, Leren P, Enger S, Holme I. High density lipoprotein cholesterol and antihypertensive drugs: the Oslo study. British Medical Journal 2: 403, 1978b

    Article  PubMed  CAS  Google Scholar 

  • Holland OB, Nixon JV, Kuhnert LV. Diuretic-induced ventricular ectopic activity. American Journal of Medicine 70: 762–768, 1981

    Article  PubMed  CAS  Google Scholar 

  • Horgan JH, O’Donovan A, Teo KK. Echocardiographic evaluation of left ventricular function in patients showing an antihypertensive and biochemical response to indapamide. Postgraduate Medical Journal 57 (Suppl. 2): 64–67, 1981

    PubMed  Google Scholar 

  • Hypertension Detection and Follow-up Program (HDFP) Cooperative Group. Five-year findings of the Hypertension Detection and Follow-up Program. I. Reduction in mortality of persons with high blood pressure, including mild hypertension. Journal of the American Medical Association 242: 2562–2571, 1979

    Article  Google Scholar 

  • Hypertension Detection and Follow-up Program (HDFP) Cooperative Group. Five-year findings of the Hypertension Detection and Follow-up Program. III. Reduction in stroke incidence among persons with high blood pressure. Journal of the American Medical Association 247: 633–638, 1982

    Article  Google Scholar 

  • Hypertension Detection and Follow-up Program Cooperative Group. Effect of stepped care treatment on the incidence of myocardial infarction and angina pectoris. Hypertension 6 (Suppl. I): I–198–I–206, 1984

    Google Scholar 

  • Johnson B, Bye C, Labrooy J, Munro-Faure D, Slack J. The relation of antihypertensive treatment to plasma lipids and other vascular risk factors in hypertension. Clinical Science and Molecular Medicine 47: 9–10, 1974

    Google Scholar 

  • Johnson BF. The emerging problem of plasma lipid changes during antihypertensive therapy. Journal of Cardiovascular Pharmacology 4 (Suppl. 2): S213–S221, 1982

    Article  PubMed  Google Scholar 

  • Johnson BJ, Romero L, Johnson J, Marwaha R. Comparative effects of propranolol and prazosin upon serum lipids in thiazide-treated hypertensive patients. American Journal of Medicine 76(2A): 109–112, 1984

    Article  PubMed  CAS  Google Scholar 

  • Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure. The 1984 report of the Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure. Archives of Internal Medicine 144: 1045–1057, 1984

    Article  Google Scholar 

  • Jones JU, Dunn FG, Fife R, Lorimer AR, Kellett RG. Benzothiadizine diuretics and death from myocardial infarction in hypertension. Clinical Science and Molecular Medicine 55: 315S–317S, 1978

    CAS  Google Scholar 

  • Joos C, Kewitz H, Reinhold-Kourniati D. Effects of diuretics on plasma lipoproteins in healthy men. European Journal of Clinical Pharmacology 17: 251–257, 1980

    Article  PubMed  CAS  Google Scholar 

  • Kannel WB. Handbook of coronary risk probability, American Heart Association, New York, 1972

    Google Scholar 

  • Kannel WB, Castelli WP, Gordon T. Cholesterol in the prediction of atherosclerotic diseases. Annals of Internal Medicine 90: 85–91, 1979

    PubMed  CAS  Google Scholar 

  • Kannel WB, Dawber JR. Hypertension as an ingredient of the cardiovascular risk profile. British Journal of Hospital Medicine 11: 500–523, 1974

    Google Scholar 

  • Kannel WB, Gordon T, McGee D. Diuretics and serum cholesterol. Correspondence. Lancet 1: 1362–1363, 1977

    Article  CAS  Google Scholar 

  • Lasser NL, Grandits G, Caggiulla AW, Cutler JA, Grimm Jr RH, et al. Effects of antihypertensive therapy on plasma lipids and lipoproteins in the Multiple Risk Factor Intervention Trial. American Journal of Medicine 76(2A): 52–66, 1984

    Article  PubMed  CAS  Google Scholar 

  • Leren P, Eide I, Foss OP, Helgeland A, Hjermann I, et al. Antihypertensive drugs and blood lipids: the Oslo study. Journal of Cardiovascular Pharmacology 4: S222–S224, 1982

    Article  PubMed  Google Scholar 

  • Leth A. Changes in plasma and extracellular fluid volumes in patients with essential hypertension during long-term treatment with hydrochlorothiazide. Circulation 42: 479–485, 1970

    Article  PubMed  CAS  Google Scholar 

  • Logan RL, Thomson M, Riemersma RA, Oliver MF, Olsson AG, et al. Risk factors for ischemic heart disease in normal men aged 40. Lancet 1: 949–955, 1978

    Article  PubMed  CAS  Google Scholar 

  • Medical Research Council Working Party. MRC trial of treatment of mild hypertension: principal results. British Medical Journal 291: 97–104, 1985

    Article  Google Scholar 

  • Meier A, Weidmann P, Mordasini R, Riesen W, Bachmann C. Reversal or prevention of diuretic-induced alterations in serum lipoproteins with beta blockers. Atherosclerosis 41: 415–419, 1982

    Article  PubMed  CAS  Google Scholar 

  • Mironneau J, Gargouil YM. Actions de l’indapamide sur la musculature lisse. Revue Medicine 18: 1587–1590, 1977

    Google Scholar 

  • Morgan TO, Adams WR, Hodgson M, Gibbend RW. Failure of therapy to improve prognosis in elderly males with hypertension. Medical Journal of Australia 2: 27–31, 1980

    PubMed  CAS  Google Scholar 

  • Morledge JH. Clinical efficacy and safety of indapamide in essential hypertension. American Heart Journal 106: 229–232, 1983

    Article  PubMed  CAS  Google Scholar 

  • Multiple Risk Factor Intervention Trial (MRFIT) Research Group. Multiple risk factor intervention trial. Journal of the American Medical Association 248: 1465–1477, 1982

    Article  Google Scholar 

  • Perera GA. Diagnosis and natural history of hypertensive vascular disease. American Journal of Medicine 4: 416–422, 1948

    Article  PubMed  CAS  Google Scholar 

  • Report by the Management Committee. The Australian therapeutic trial in mild hypertension. Lancet 1: 1261–1267, 1980

    Google Scholar 

  • Scalabrino A, Galeone F, Giuntoli F, Guidi G, Birindelli A, et al. Clinical investigation on long-term effects of indapamide in patients with essential hypertension. Current Therapeutic Research 35: 17–22, 1984

    Google Scholar 

  • Schiffl H, Weidmann P, Mordasini R, Riesen W, Bachmann C. Reversal of diuretic-induced increases in serum low-density lipoprotein cholesterol by the beta blocker pindolol. Metabolism 31: 411–415, 1982

    Article  PubMed  CAS  Google Scholar 

  • Schoenfeld MR, Goldberger E. Hypercholesterolemia induced by thiazides: a pilot study. Current Therapeutic Research 6: 180–184, 1964

    PubMed  CAS  Google Scholar 

  • Shah S, Khatri I, Freis ED. Mechanism of antihypertensive effect of thiazide diuretics. American Heart Journal 95: 611–618, 1978

    Article  PubMed  CAS  Google Scholar 

  • Smith WM. Treatment of mild hypertension. Results of a ten-year intervention trial. Circulation Research40 (Suppl. 1): 98–105, 1977

    Article  Google Scholar 

  • Stamler J. Population studies. In evy et al. (Eds) Nutrition, lipids, and coronary heart disease, p. 72, Raven Press, New York, 1979

    Google Scholar 

  • Steinbrechen UP, Witztum JL. Glucosylation of low-density lipoproteins to an extent comparable to that seen in diabetes slows their catabolism. Diabetes 33: 130–134, 1984

    Article  Google Scholar 

  • Tarazi RC, Dustan HP, Frohlich ED. Long-term thiazide therapy in essential hypertension. Circulation 41: 709–717, 1970

    Article  PubMed  CAS  Google Scholar 

  • Valimaki M, Harna K, Nikkila EA. Serum lipoproteins and indices of glucose tolerance during diuretic therapy: a comparison between hydrochlorothiazide and piretanide. Journal of Cardiovascular Pharmacology 4: 525–530, 1983

    Article  Google Scholar 

  • VanBrummelen P, Gevers Leuven VA, Van Gent CM. Influence of hydrochlorothiazide on the plasma levels of triglycerides, total cholesterol and HDL-cholesterol in patients with hypertension. Current Medical Research and Opinion 6:24–29, 1979

    Article  PubMed  Google Scholar 

  • Veterans Administration Cooperative Study Group on Antihypertensive Agents: Effects of treatment on morbidity in hypertension. I. Results in patients with diastolic blood pressures averaging 115 through 129mm Hg. Journal of the American Medical Association 202: 1028–1034, 1967

    Google Scholar 

  • Veterans Administration Cooperative Study Group on Antihypertensive Agents. Effects of treatment on morbidity in hypertension. II. Results in patients with diastolic blood pressures averaging 90 through 114mm Hg. Journal of the American Medical Association 213: 1143–1152, 1970

    Article  Google Scholar 

  • Veterans Administration Cooperative Study Group on Antihypertensive Agents. Comparative effects of ticrynafen and hydrochlorothiazide in treatment of hypertension. New England Journal of Medicine 301: 293–297, 1979

    Article  Google Scholar 

  • Veterans Administration Cooperative Study Group on Antihypertensive Agents. Comparison of propranolol and hydrochlorothiazide for the initial treatment of hypertension. I. Results in short-term titration with emphasis on racial differences in response. Journal of the American Medical Association 248: 1996–2003, 1982a

    Article  Google Scholar 

  • Veterans Administration Cooperative Study Group on Antihypertensive Agents. Comparison of propranolol and hydrochlorothiazide for the initial treatment of hypertension. II. Results of long-term therapy. Journal of the American Medical Association 248: 2004–2011, 1982b

    Article  Google Scholar 

  • Veterans Administration Cooperative Study Group on Antihypertensive Agents. Efficacy of nadolol alone and combined with bendroflumethiazide and hydralazine for systemic hypertension. American Journal of Cardiology 52: 1230–1237, 1983

    Article  Google Scholar 

  • Weidmann P, Meier A, Mordasini R, Riesen W, Bachmann C, et al. Diuretic treatment and serum lipoproteins: effects of tienilic acid and indapamide. Klinische Wochenschrift 59: 343–346, 1981

    Article  PubMed  CAS  Google Scholar 

  • Weidmann P, Schiffl H, Mordasini R, Meier A, Boehringer K, et al. Effects of diuretics alone or in combination with betablockers on serum lipoproteins. In Noseda et al. (Eds) Lipoproteins and coronary atherosclerosis, pp. 363–370, Elsevier Biomedical Press, Amsterdam, 1982

    Google Scholar 

  • Weidmann P, Gerber A. Effects of treatment with diuretics on serum lipoproteins. Journal of Cardiovascular Pharmacology 6: S260–S268, 1984

    Article  PubMed  Google Scholar 

  • Wilcox RG. Randomized study of six beta-blockers and a thiazide diuretic in essential hypertension. British Medical Journal 2: 383–385, 1978

    Article  PubMed  CAS  Google Scholar 

  • Williams HR, Borhani NO, Schnaper WH, Schneider KA, Slotkoff L. The relationship between diuretics and serum cholesterol in HDFP participants. Abstract. Journal of the American College of Cardiology 1: 623, 1983

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. St Luke’s-Roosevelt Hospital and College of Physicians and Surgeons, Columbia University, 428 West 59th Street, New York, NY, 10019, USA

    Richard P. Ames

Authors
  1. Richard P. Ames
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ames, R.P. The Effects of Antihypertensive Drugs on Serum Lipids and Lipoproteins. Drugs 32, 260–278 (1986). https://doi.org/10.2165/00003495-198632030-00003

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00003495-198632030-00003

Keywords

Search

Navigation